In­di­vumed, IMCB to build mul­ti­omics cancer data­base

BioSpectrum (Asia) - - Academics News -

In­di­vumed GmbH and A*STAR’s In­sti­tute of Molec­u­lar and Cell Bi­ol­ogy (IMCB) in Sin­ga­pore have signed an agree­ment to per­form pro­teomic and phos­pho­pro­teomic anal­y­sis of thou­sands of tis­sue sam­ples from In­di­vumed’s unique biobank. This con­trib­utes to In­di­vumed’s global cancer data­base so­lu­tion In­di­vuType, funded by the Euro­pean In­vest­ment Bank and pri­vate in­vestors. In­di­vuType com­bines com­pre­hen­sive cell bi­o­log­i­cal in­for­ma­tion such as ge­nomic, tran­scrip­tomic, pro­teomic, pre­ci­sion pro­teomic, and dig­i­tal histopathol­ogy data with ex­ten­sive clin­i­cal in­for­ma­tion from thou­sands of pa­tients. A por­tal IT so­lu­tion with a va­ri­ety of cut­ting-edge bioin­for­matic and artificial in­tel­li­gence tools en­ables cancer re­searchers and clin­i­cians to com­pre­hen­sively an­a­lyze and un­der­stand the com­plex­ity of the disease.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.